Table 2.
Rates of adverse events within 72 hours after immunisation using LAIV compared with rates in the literature
Symptoms within 72 hours | No (%) in study (n=779) | Rates in literature (%) |
---|---|---|
Allergic reaction (mild symptoms) only | 9 (1.2) | 0.02 |
Allergic reaction: anaphylaxis | 0 (0) | 0 |
Fever | 39 (5.0) | 5.4 |
Nasal symptoms | 141 (18.1) | 31 |
Wheeze (parent reported) | 29 (3.7) | NR |
Wheeze requiring treatment by doctor | 3 (0.4) | 0.2 |
Lower respiratory tract symptoms | 62 (8.0) | NR |
Eczema flare | 22 (2.8) | NR |
NR=not reported.
Rates reported as proportion of total number of doses given, to be consistent with method of reporting used in existing literature.15